Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

Jacqueline A. French, Bassel Abou‐Khalil, Robert Leroy, Elza Márcia Targas Yacubian, Paul Shin, Susan T. Hall, Harry H. Mansbach, Virinder Nohria

Neurology · 2011 · 181 citations · 31 references

Abstract

This study provides Class II evidence that EZG(RTG) 1,200 mg/day is effective as adjunctive therapy in adults with partial-onset seizures with or without secondary generalization.

References

31